Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $26.27-$67.53 |
Market Cap | $4.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $754M |
Revenue Growth (YoY) | 55.5% |
Gross Profit (12 Mos) | $412.1M |
Diluted EPS | $0.91 |
News
See moreYahoo Finance • 20 days ago
Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth
Yahoo Finance • 2 months ago
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Yahoo Finance • 2 months ago
High Growth Tech Stocks in the US for May 2026
Yahoo Finance • 2 months ago
Hedge Funds Followed the April Equity Rally by Increasing Exposure to Technology Leaders, Hazeltree Finds
About
CEO | Mr. Sanjiv K. Patel |
CFO | Mr. Mark A. Ragosa C.F.A. |
Address | 105 Piccadilly, London, United Kingdom, W1J 7NJ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 366 |